1-10 of 10
Xia Han
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 5186: Higher levels of circulating exhausted T-cells at pre- and post-infusion negatively associated with clinical efficacy in tisagenlecleucel (Tisa-cel) treated relapsed/refractory large B-cell lymphoma (r/r LBCL) patients (pts) in JULIET trial

Ulrich Jäger, Xia Han, Davide Germano, David Quinn, Dalia Gaddis, Aisha Masood, Tanya Mulvey, Jennifer Mataraza, Michael R. Bishop, Gilles Salles, Richard Maziarz, Stephen Schuster
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 5186.
https://doi.org/10.1158/1538-7445.AM2022-5186
Published: 15 June 2022
View article titled, Abstract 5186: Higher levels of circulating exhausted T-cells at pre- and post-infusion negatively associated with clinical efficacy in tisagenlecleucel (Tisa-cel) treated relapsed/refractory large B-cell lymphoma (r/r LBCL) patients (pts) in JULIET trial
Journal Articles

Abstract CT077: Potential utility of minimal residual disease (MRD) to identify relapse in pediatric and young adult (AYA) B-cell acute lymphoblastic leukemia (B-ALL) patients treated with tisagenlecleucel

Michael A. Pulsipher, Xia Han, Máire Quigley, Gabor Kari, Susana Rives, Theodore W. Laetsch, Gary D. Myers, Hidefumi Hiramatsu, Gregory A. Yanik, Muna Qayed, Timothy Driscoll, Michael W. Boyer, Heather Stefanski, Jochen Buchner, Andre Baruchel, Peter Bader, Lan Yi, Creton Kalfoglou, Harlan Robins, Erik Yusko, Gullu Gorgun, Eric Bleickardt, Stephane Wong, Stephan A. Grupp
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): CT077.
https://doi.org/10.1158/1538-7445.AM2019-CT077
Published: 01 July 2019
View article titled, Abstract CT077: Potential utility of minimal residual disease (MRD) to identify relapse in pediatric and young adult (AYA) B-cell acute lymphoblastic leukemia (B-ALL) patients treated with tisagenlecleucel
Journal Articles

Twist1 Regulates Vimentin through Cul2 Circular RNA to Promote EMT in Hepatocellular Carcinoma

Jing Meng, Shuang Chen, Jing-Xia Han, Baoxin Qian, Xiao-Rui Wang, Wei-Long Zhong, Yuan Qin, Heng Zhang, Wan-Feng Gao, Yue-Yang Lei, Wei Yang, Lan Yang, Chao Zhang, Hui-Juan Liu, Yan-Rong Liu, Hong-Gang Zhou, Tao Sun, Cheng Yang
Journal: Cancer Research
Series: Author Choice
Cancer Res (2018) 78 (15): 4150–4162.
https://doi.org/10.1158/0008-5472.CAN-17-3009
Published: 31 July 2018
View article titled, Twist1 Regulates Vimentin through Cul2 Circular RNA to Promote EMT in Hepatocellular Carcinoma
Open the PDF for Twist1 Regulates Vimentin through Cul2 Circular RNA to Promote EMT in Hepatocellular Carcinoma in another window
Includes: Supplementary data
Journal Articles

Abstract DDT01-03: Discovery of BMS-911543, a highly selective JAK2 inhibitor, as a clinical candidate for the treatment of myeloproliferative disease and other malignancies

Ashok V. Purandare, Honghe Wan, Gretchen Schroeder, Amy Hart, James Grebinski, Jennifer Inghrim, John Tokarski, Dan You, Becky Penhallow, Theresa McDevitt, Ragini Vuppugalla, Yueping Zhang, Stefan Ruepp, George Trainor, Xia Han, Louis Lombardo, Francis Y. Lee, Marco Gottardis, Jennifer Hosbach, Elizabeth Fitzpatrick, Stuart Emanuel, Animesh Pardanani, Terra L. Lasho, Ayalew Tefferi, Matthew V. Lorenzi
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): DDT01-03.
https://doi.org/10.1158/1538-7445.AM2011-DDT01-03
Published: 15 April 2011
View article titled, Abstract DDT01-03: Discovery of BMS-911543, a highly selective JAK2 inhibitor, as a clinical candidate for the treatment of myeloproliferative disease and other malignancies
Journal Articles

The Mechanisms of Differential Sensitivity to an Insulin-like Growth Factor-1 Receptor Inhibitor (BMS-536924) and Rationale for Combining with EGFR/HER2 Inhibitors

Fei Huang, Ann Greer, Warren Hurlburt, Xia Han, Rameh Hafezi, Gayle M. Wittenberg, Karen Reeves, Jiwen Chen, Douglas Robinson, Aixin Li, Francis Y. Lee, Marco M. Gottardis, Edwin Clark, Lee Helman, Ricardo M. Attar, Ashok Dongre, Joan M. Carboni
Journal: Cancer Research
Cancer Res (2009) 69 (1): 161–170.
https://doi.org/10.1158/0008-5472.CAN-08-0835
Published: 31 December 2008
View article titled, The Mechanisms of Differential Sensitivity to an Insulin-like Growth Factor-1 Receptor Inhibitor (BMS-536924) and Rationale for Combining with EGFR/HER2 Inhibitors
Open the PDF for The Mechanisms of Differential Sensitivity to an Insulin-like Growth Factor-1 Receptor Inhibitor (BMS-536924) and Rationale for Combining with EGFR/HER2 Inhibitors in another window
Includes: Supplementary data
Journal Articles

Effects of brivanib alaninate on FGF2-induced proliferation in human cancer cell lines

Mark Ayers, Suganthy Yoganathan, Xia Han, Shujian Wu, Vishal Patel, Aiqing He, Edwin Clark, Joseph Fargnoli
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 3321.
Published: 01 May 2008
View article titled, Effects of brivanib alaninate on FGF2-induced proliferation in human cancer cell lines
Journal Articles

Comparison of a dual inhibitor of VEGF and FGF signaling, BMS-582664, to the activity of bevacizumab, an inhibitor exclusively of VEGF signaling, in xenograft models of colon carcinoma.

Mark Ayers, Gennaro Dito, Benjamin Henley, Robert Jeyaseelan, Suganthy Yoganthan, Xia Han, Qiuyan Wu, Suso Platero, Shujian Wu, David Feltquate, Edwin Clark, Joseph Fargnoli
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 1618.
Published: 01 May 2007
View article titled, Comparison of a dual inhibitor of VEGF and FGF signaling, BMS-582664, to the activity of bevacizumab, an inhibitor exclusively of VEGF signaling, in xenograft models of colon carcinoma.
Journal Articles

Identification of Candidate Molecular Markers Predicting Sensitivity in Solid Tumors to Dasatinib: Rationale for Patient Selection

Fei Huang, Karen Reeves, Xia Han, Craig Fairchild, Suso Platero, Tai W. Wong, Francis Lee, Peter Shaw, Edwin Clark
Journal: Cancer Research
Cancer Res (2007) 67 (5): 2226–2238.
https://doi.org/10.1158/0008-5472.CAN-06-3633
Published: 01 March 2007
View article titled, Identification of Candidate Molecular Markers Predicting Sensitivity in Solid Tumors to Dasatinib: Rationale for Patient Selection
Open the PDF for Identification of Candidate Molecular Markers Predicting Sensitivity in Solid Tumors to Dasatinib: Rationale for Patient Selection in another window
Includes: Supplementary data
Journal Articles

Transcriptional characteristics of genomic instabilities for colorectal cancer patients

Xia Han, Edwin Clark, Peter M. Shaw, Ayan Banerjea, Shafi Ahmed, Michael P. Powar, Rebecca E. Hands, Stephen A. Bustin, Sina Dorudi, Fei Huang
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 840.
Published: 01 May 2005
View article titled, Transcriptional characteristics of genomic instabilities for colorectal cancer patients
Journal Articles

Gene expression profiling as a predictor of outcome in colorectal cancer patients

Xia Han, Shafi Ahmed, Michael P. Powar, Ayan Banerjea, Sina Dorudi, Edwin Clark, Peter M. Shaw, Fei Huang
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 1165.
Published: 01 April 2004
View article titled, Gene expression profiling as a predictor of outcome in colorectal cancer patients